BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 16, 2003
View Archived Issues
MIT Scientist Rejects Mutagenic Cause of Neoplasms; Espouses Outside Factors Over Mutations
Read More
Industry Reps Continue Debating The Issue Of Generic Biologics
Read More
Several Hybridon Presentations Highlight Early Cancer Platform
Read More
Other News To Note
Read More
Trimeris, Roche Increase Capacity For Fuzeon, Release More Data
Reports of increased global supplies of Fuzeon, coupled with longer-term data on the product, gave Trimeris Inc. a boost from investors eyeing higher earnings from early sales of the FDA-approved HIV drug. (BioWorld Today)
Read More
Medivir, Boehringer Ingelheim Enter Potential EUR122M Alliance
Read More